title: [Does carvedilol minimize the requirements for laser photocoagulation in diabetic retinopathy?].
authors.forename: I
authors.initials: I
authors.lastname: Auyanet
authors.forename: L J
authors.initials: LJ
authors.lastname: Rodríguez
authors.forename: N
authors.initials: N
authors.lastname: Esparza
authors.forename: F
authors.initials: F
authors.lastname: Cabrera
authors.forename: P
authors.initials: P
authors.lastname: Rossique
authors.forename: S
authors.initials: S
authors.lastname: Suria
authors.forename: P
authors.initials: P
authors.lastname: Cardona
authors.forename: M D
authors.initials: MD
authors.lastname: Checa
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use*; D000077261:Carvedilol; D003928:Diabetic Nephropathies / Q000150:complications / Q000188:drug therapy; D003930:Diabetic Retinopathy / Q000150:complications / Q000601:surgery*; D005260:Female; D006801:Humans; D017075:Laser Coagulation; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol